Respiratory News and Research

RSS

How is long-COVID different from other post-viral infection syndromes?

The symptoms, illness duration, long-term clinical traits, and possible healthcare burden of post-viral conditions in children and adolescents under 20 years.

6 Feb 2024

Paxlovid enhances treatment options for COVID-19 patients

The design, synthesis, and mechanism of action of Paxlovid.

6 Feb 2024

SARS-CoV-2 fragments found to mimic immune system peptides, fueling inflammation

Study reveals SARS-CoV-2 fragments mimic immune peptides, potentially driving the virus's inflammatory response, offering insights into COVID-19's severe inflammation mechanisms.

5 Feb 2024

Long-COVID recovery insight: Fatigue and cognitive deficits improve over two years

Study reveals improvements in cognitive deficits and fatigue among long-COVID patients over two years, with specific risk factors like depressive symptoms and old age predicting non-recovery.

5 Feb 2024

COVID-19 recovery disparities uncovered among racial and ethnic groups

Study reveals ethnic and racial disparities in health outcomes post-COVID-19 infection, with Hispanic and racial minority groups reporting poorer health status and increased work absence compared to their non-Hispanic and White counterparts.

4 Feb 2024

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection

Early estimates show the 2023-24 updated monovalent XBB.1.5 COVID-19 vaccine offers significant protection against symptomatic infection, with effectiveness varying by age and time since vaccination.

4 Feb 2024

Has a decade of maternal pertussis vaccination reduced its effectiveness?

Research indicates maternal immunization against pertussis remains crucial for newborn protection despite concerns of reduced vaccine effectiveness over time, underscoring its vital role in preventing infant mortality.

3 Feb 2024

Machine learning can help predict the risk of bacterial co-infections in hospitalized COVID-19 patients

University of Queensland researchers have used machine learning to help predict the risk of secondary bacterial infections in hospitalized COVID-19 patients.

2 Feb 2024

Are urban green spaces beneficial to air quality?

Study reveals that urban green space has a limited impact on air pollution control, with street-level vegetation potentially increasing pollution by hindering ventilation.

1 Feb 2024

Phase II clinical trial evaluates the safety and efficacy of a Muse cell-based product in patients with ALS

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive loss of motor functions, which eventually leads to death within 5 years of its onset.

1 Feb 2024

BIPOC individuals infected with COVID-19 experienced greater negative aftereffects in health

Black, indigenous, and people of color (BIPOC) who were infected with COVID-19 experienced greater negative aftereffects in health and work loss than did similarly infected white participants, new research finds.

1 Feb 2024

New sequencing tool speeds up SARS-CoV-2 outbreak response and informs treatment

Announcing a new article publication for Zoonoses journal. In the context of two Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) outbreaks involving local transmission and an international flight, the authors of this article used meta-transcriptome and multi-amplicon sequencing to successfully acquire the complete viral genome sequences from clinical samples with varying viral loads.

1 Feb 2024

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

study identifies risk factors for prolonged SARS-CoV-2 infection in immunocompromised patients, revealing that B-cell dysfunction, solid organ transplantation, and AIDS lead to longer infections and unique spike mutations.

31 Jan 2024

Mechanically ventilated patients in intermediate care units of rural hospitals have higher death rates

A new National Institutes of Health-supported study finds that patients receiving ventilator life support in the intermediate care units – a potentially less costly alternative for people not sick enough for the intensive care units (ICUs) but too ill for the general ward – of rural hospitals had significantly higher death rates than patients in the same type of unit at urban hospitals.

31 Jan 2024

Bronchoscopy skills of medics may improve with video gaming, says study

The effect of video gaming on bronchoscopy skills among medical students and residents.

31 Jan 2024

Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory disease, today announced that it has closed a £26 million ($33.1 million USD) Series B follow-on financing round, led by Panakes Partners.

From Enterprise Therapeutics Ltd 31 Jan 2024

Gut microbiome may hold key to fighting common respiratory viruses

The composition of microbiota found in the gut influences how susceptible mice are to respiratory virus infections and the severity of these infections, according to researchers from the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University.

30 Jan 2024

Respiratory News and Research

How is long-COVID different from other post-viral infection syndromes?

Paxlovid enhances treatment options for COVID-19 patients

SARS-CoV-2 fragments found to mimic immune system peptides, fueling inflammation

Long-COVID recovery insight: Fatigue and cognitive deficits improve over two years

COVID-19 recovery disparities uncovered among racial and ethnic groups

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection

Has a decade of maternal pertussis vaccination reduced its effectiveness?

Machine learning can help predict the risk of bacterial co-infections in hospitalized COVID-19 patients

Are urban green spaces beneficial to air quality?

Phase II clinical trial evaluates the safety and efficacy of a Muse cell-based product in patients with ALS

BIPOC individuals infected with COVID-19 experienced greater negative aftereffects in health

New sequencing tool speeds up SARS-CoV-2 outbreak response and informs treatment

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

Mechanically ventilated patients in intermediate care units of rural hospitals have higher death rates

Bronchoscopy skills of medics may improve with video gaming, says study

Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing

Gut microbiome may hold key to fighting common respiratory viruses

Resin ingredient strongly decreases coronavirus infectivity on plastic surfaces

Impact of nirsevimab immunization on pediatric RSV-related hospitalizations in Luxembourg

New research highlights regional variations in COPD prevalence according to diagnostic criteria

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News